Angiotensin II, TGF-beta and renal fibrosis.
Gaedeke
J
J
Fibrosis Research Laboratory, Division of Nephrology, University of Utah, Salt Lake City, Utah, USA.
Peters
H
H
Noble
N A
NA
Border
W A
WA
D000804:Angiotensin II / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D004195:Disease Models, Animal; D005355:Fibrosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000473:pathology*; D007674:Kidney Diseases / Q000209:etiology / Q000473:pathology*; D051381:Rats; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016212:Transforming Growth Factor beta / Q000009:adverse effects* / Q000378:metabolism
D016212:Transforming Growth Factor beta; D000804:Angiotensin II